The c-myb protooncogene plays a major role in regulating the process of in vitro and in vivo hematopoiesis via its activity as transcriptional regulator in hematopoietic progenitor cells. Since the bone marrow microenvironment appears to regulate in vivo hematopoiesis by maintaining the growth of multipotent progenitors via secretion of specific cytokines, we asked whether c-myb is also required for the proliferation of and/or cytokine production by stromal cells that generate fibroblast-like colonies (fibroblast colony-forming units [CFU-F]). Using the reverse transcriptase polymerase chain reaction technique, we detected low levels of c-myb mRNA transcripts in human normal bone marrow fibroblasts. Treatment of these cells with c-myb antisense oligodeoxynucleotides caused downregulation of c-myb expression, decrease in the number of marrow CFU-F colonies (,x,54% inhibition) and in the cell number within residual colonies (~80%), and downregulation of granulocyte/macrophage colony-stimulating factor (GM-CSF) and stem cell factor (SCF) mRNA expression. Transfection ofT98G glioblastoma cells, in which expression of c-myb, GM-CSF, and SCF mRNAs is undetectable or barely detectable, with a plasmid containing a full-length c-myb cDNA under the control of the SV40 promoter induced the expression of biologically active SCF and GM-CSF in these cells. Regulation of GM-CSF expression by c-myb was due in part to transactivation of the GM-CSF promoter. These results indicate that, in addition to regulating hematopoietic cell proliferation, c-myb is also required for proliferation of and cytokines synthesis by bone marrow fibroblasts.
H
ematopoietic tissue is constantly renewed through the proliferation and differentiation of stem cells residing in the bone marrow in close contact with multiple adherent (stromal) cells that comprise the hematopoietic microenvironment (HM) (1) (2) (3) (4) . In vitro stromal cells form fibroblast colonies (CFU-F) that, under defned conditions support longterm bone marrow growth of primitive hematopoietic stem cells (long-term bone marrow cultures [LTBMC] 1 or Dexter-type cultures) (1) (2) (3) (4) . The interactions between the hematopoietic cells and the microenvironment are still poorly understood, due to the cellular heterogeneity of this microenvironment and to the difficulties in isolating homogeneous populations of its components for genetic and functional studies. The development of the PCR technology has enabled detection of growth factor transcripts in stromal marrow fibroblasts, suggesting that, via these cytokines, these cells 1 Abbreviations used in this paper: LTBMC, long-term bone marrow culture; NBM, normal bone marrow; SCF, stem cell factor.
play an important role in hematopoiesis in mammals in vivo (5, 6) .
Different experimental approaches have revealed that the protooncogene c-myb plays an important role in regulating not only hematopoietic cell growth (7) (8) (9) (10) , but also proliferation of nonhematopoietic cells (11) (12) (13) . Treatment with synthetic c-myb antisense oligodeoxynucleotides inhibits formation of colonies derived from normal hematopoietic progenitors (7) (8) (9) . Inactivation of the endogenous c-myb gene by homologous recombination in mouse embryonic stem cells drastically impairs liver hematopoiesis (10) . To address the possibility that c-myb also regulates stromal cell function, we measured c-myb mRNA levels in bone marrow fibroblasts and assessed whether downregulation of c-rnyb expression affects proliferation and cytokine production of these cells.
Materials and Methods
Cells and Cell Cultures. Bone marrow aspirates were obtained from the iliac crest of healthy individuals after informed consent.
The cell suspensions were diluted 1:4 with IMDM, layered on Ficoll/Histopaque density gradient, and centrifuged for 30 min at 1,500 rpm. Light-density mononuclear cells were washed in the same medium, and plated (5 x 10 s cells/dish) into 35-mm petri dishes (Nunc, Inc., Naperville, IL) in IMDM supplemented with 15% FCS. After 90 min, supernatant containing nonadherent cells was discarded and the remaining adherent cells were cultured. Culture medium was changed every 3 d. After a 14-d culture, the number of colonies was counted under light microscope after staining with 5% crystal violet for 8 min. Cells to be used for KNA extraction were grown as monolayers, washed twice with HBSS, passaged four times, washed with IMDM, and lysed with lysing solution directly in the plates. The cell composition of this population of stromal cells was analyzed by surface phenotyping as described below. T98G human glioblastoma cells and TK-ts13 hamster fibroblasts (kind gifts of Drs. E. Mercer and R. Baserga, respectively) were maintained in culture as described (14, 15) .
Indirect Immunofluorescence. Cells were grown on chamber slides (Nunc, Inc.) to subconfluence. The slides were rinsed with PBS and fixed with ice-cold 100% ethanol. After a 30-rain incubation with 1% BSA in PBS the samples were exposed to either factor VIII (Dako, Denmark), CD14, CDw32, or type I collagen (ICN, Costa Mesa, CA) mAbs for 45 min at room temperature. The slides were then rinsed with PBS and exposed to rhodamine-or fluoresceine-conjungated anti-mouse IgG mAbs (Cappel Laboratories, West Chester, PA) for 45 min. Nonadherent secondary antibodies were then washed off with PBS. Nonspecific binding of the antibodies was excluded by performing controls with secondary antibodies only. In additional controls, microvascular endothelial cells were stained with antibodies to factor VIII.
Oligomers and Primers. These were synthesized on a DNA synthesizer (308B; Applied Biosystems, Inc., Foster City, CA) by means of B-cyanoethyl-phosphorymidite chemistry as described (7) . The sequences of the c-myb sense and antisense oligodeoxynucleotides used were: 5'-GCC CGA ACA CCC CGG CAC-3' and 5'-GTG CCG GGG TCT TGG GGC-3', respectively, c-myb mKNA was detected by reverse transcriptase (KT)-PCK amplification of a segment ofc-myb mKNA in the 3' untranslated region with a 5' synthetic primer, 5'-ATT AGG TAA TGA ATT GTA GCC AG-3', and a 3' synthetic primer, 5'-ACT TAG AGT AAT GCT TTT ACT GA-3'. The amplification product was detected by hybridization to the synthetic oligomer included in the amplified fragment (5'-ATT TTT TTA AAA AAA AAC ATA AAA TGA TTT ATC  TAT TTT AAA GGA TCC-Y) encompassing nucleotides 2351-2400 of the human c-myb cDNA (16) ./3-Actin mKNA levels were also analyzed by KT-PCK. The 5' primer corresponds to nucleotides 224-244; the 3' primer corresponds to nucleotides 411-433 of/3-actin cDNA. A 39-base probe used to detect the amplification product corresponds to nucleotides 258-296 (17) . GM-CSF mRNA was detected by KT-PCK technique with a pair of synthetic primers: 5' primer, 5'-ATG TGA ATG CCA TCC AGG AG-3'; 3' primer, 5'-CTT GTA GTG GCT GGC CAT CA-3' and detected with a synthetic probe, 5'-TAG AGA CAC TGC TGC TGA GA-3' (18). Stem cell factor (SCF) mKNA was detected using the following set of primers: 5' primer, 5'-ATG AAG AAG ACA CAA ACT TGG-3'; 3' primer, 5'-GTC CAG AAG ATC AGT CAA GCT-3', and detected by synthetic oligomer probe, 5'-GCC GAG CTG GAC AGC ACC GTG CTC CTG ACC CGC TCT CTC-3' (19). 11,6 mKNA was detected using the following set of primers: 5' primer, 5'-AAG ATT CAT ACC TCA GAG CG-3'; 3' primer, 5'-ATG AGA TCA CCT AGT CCA CC-3'; and detected by synthetic oligomer probe, 5'-AGC CCA GAC TCG AAT TCT GGT TCT GCC AAA-3' (20) . I1,11 mRNA was detected using the following set of primers: 5' primer, 5'-ATG AAC TGT GTT TGC CGC-3'; 3' primer, 5'-CCC CTG AGC TGG GAA TTT-3'; and detected by synthetic oligomer probe, 5'-GCC GAG CTG GAC AGC ACC GTG CTC CTG ACC CGC TCT CTC-3' (21).
Otigomer Treatment of the Cells. Normal bone marrow (NBM) cells were plated into 35-mm dishes (Nunc, Inc.) in 1 ml IMDM 1640 supplemented with 15% FCS. c-myb sense and antisense oligodeoxynucleotides were added three times during a 14-d culture: 40-120/~g/ml, as indicated, was added during the first 18-24 h of incubation (37~ 5% CO2), half of the initial dose was added on day 3, and a third dose (50% of initial dose) was added on day 6 after changing the medium. On day 14, the medium was discarded, the cells were stained with 5% crystal violet for 8 min, and the number of colonies per plate and cell number per colony were determined.
Transfection. T98G human glioblastoma cells were transfected using the calcium-phosphate precipitation method (22) . Briefly, 2 x 10 s cells were either cotransfected with 10/zg of the plasmid pMbmI, which contains the human c-myb cDNA under control of the SV40 early promoter and enhancer, and 1/~g of the plasmid pLHL4, which contains the gene encoding hygromycin resistance or transfected with the plasmid pLHL4 only. After 12-d selection in culture medium containing 0.5 mg/ml of hygromycin B (Calbiochem-Behring Corp., San Diego, CA), colonies were pooled and cultured in medium containing 0.3 mg/ml of hygromycin B.
Detection of c-myt~ /~-Actin, GM-CSF, and SCF mRNA Transc@ts in Marrow Fibroblasts and in T98G Glioblastoma Ceils.
To analyze the effect of c-myb sense and antisense oligodeoxynucleotide treatment on c-myb expression, 10 s marrow fibroblasts obtained after the fourth passage were plated into 35-mm plastic dishes (Nunc, Inc.), and were left untreated or exposed to c-myb sense or antisense oligodeoxynucleotides (40 #g/ml at time 0; 20/zg/ml at 24 h); 24 h later, cells were collected separately from each experimental group, before extracting total KNA as described (23, 24) . KNA from each group was divided into four identical portions, and reverse transcribed using 400 U of Moloney routine leukemia virus RT (Bethesda Research Laboratories, Gaithersburg, MD), and 0.1 /~g of 3' primers of c-myb,/3-actin, GM-CSF, and SCF for 1 h at 37~ Resulting cDNA fragments were amplified with 5 U of Taq polyrrlerase (Perkin-Elmer-Cetus, Norwalk, CT) in the presence of 3' and 5' primers generating c-myb,/3-actin, GM-CSF, and SCF fragments during 50 cycles of PCK. Amplified DNA was subjected to electrophoresis, transferred to Zetabind nylon filters (Cuno, Inc., Meriden, CT), and detected by Southern hybridization with
[32p]ATP end-labeled c-myb,/$-actin, GM-CSF, or SCF synthetic probes, as described (21, 22) . Densitometric analysis of hybridization bands was performed using an Ultro Scan XL (Pharmacia LKB) apparatus.
GM-CSF and SCF mKNA levels were determined in 1 #g of total RNA derived from parental and SVmyb-transfected T98G cells. As positive control for the expression of GM-CSF and SCF, KNA derived from PHA-stimulated PBMC and the bladder carcinoma HTB9 line, respectively, was used. KNA from each sample was divided into four portions, and c-myb, GM-CSF, SCF, and B-actin expression was determined by KT-PCK technique. As negative control, RT-PCK amplifications were performed in the absence of RNA. 
Detection of GM-CSF and SCF in Cellfree Culture

Isolation of the 5' Flanking Region of Human GM-CSF Gene and
Plasmid Construction. A 600-bp fragment of the 5' flanking region of the human GM-CSF gene (18) was isolated by PCR amplification of placenta genomic DNA using the following primers: 5' primer, 5'-AAG CTT GCT GAG AGT GGC TGC-3'; 3' primer, 5'-CAG AGA ACT TTA GCC TTT CTC-3'. The amplified fragment was then subcloned into the SmaI site of the Bluescript vector (Strategene, La JoUa, CA), 5' of the T7 promoter, and subjected to sequence analysis to confirm its identity with the 5' flanking segment of the human GM-CSF gene. This plasmid was called GMCSF17. A CAT construct was prepared after digestion of GMCSF17 with EcoRV and HindlII to isolate the 600-bp fragment and clone it into pucCAT linearized using HindlII and SalI restriction enzymes to obtain the GMCSF fragment in sense orientation with respect to the CAT gene. This construct was named GM-CSF CAT2.
Transient CAT Analysis. CAT assays were performed as described (25) . Briefly, 2/xg of CAT reporter plasmid was transfected with or without 8 #g of effector plasmid phs 1/~g of pSV-/3-gal, which contains the bacterial/3-galactosidase gene driven by the SV40 promoter as an internal control of transfection ef~ciency, into wildtype or SV-rayb-transfected Tk-ts13 Syrian hamster fibrobhsts using the calcium-phosphate precipitation method (22) . 48 h after transfection, cells were harvested and proteins were extracted by freeze/thawing and normalized for transfection efficiency by B-gahctosidase assay as described by the manufacturer (Promega Biotec, Madison, WI). For each assay, cellular lysates were incubated with [14C]chloramphenicol and acetyl-CoA for 1 h at 37~ Transactivation of reporter constructs was assayed measuring the amount of acetylated [14C]chloramphenicol by thin-layer chromatography followed by autoradiography and scintillation counting.
Results
Detection of c-myb mRNA in Bone Marrow
Stromal Fibroblasts, c-myb mRNA levels are relatively abundant in undifferentiated and proliferating hematopoietic cells but are undetectable or present in few copies in other normal cell types. To determine whether c-myb mRNA is present in marrow stromal fibroblasts and to compare its expression to that found in hematopoietic cells, R N A was extracted from an equal number of cells from different sources and mRNA levels were measured by RT-PCIL analysis (Fig. 1) . High levels of c-myb m R N A were detected in the myeloid leukemia cell line HL 60 (Fig. 1, lane a) showed an intense staining for type I collagen, and were negative for the expression of factor VIII, CD14, and CDw32 normally expressed by endothelial cells and megakaryocytes, and by monocyte/macrophages respectively. These results and the characteristic morphology of the cells indicate that the culture consisted of fibroblasts only, in agreement with a published study (6) . c-myb mRNA expression was easily detected at similar levels in untreated (Fig. 3 a) and sense-treated stromal cells (Fig. 3 b) , whereas significantly lower c-myb mlkNA levels were present in cells treated with c-myb antisense oligonucleotides (Fig. 3 c) . Densitometric measurement of the c-myb hybridizing bands in sense-vs.-antisense oligodeoxynucleotide-treated samples indicated that the signal from the antisense-treated samples was <10% of that from the sensetreated sample.
To determine whether inhibition of c-myb expression affected stromal fibroblast cell functions, we investigated GM-CSF, SCF, IL-6, and IL-11 mRNA levels in c-myb sense-or antisense-treated cultures in four different experiments. High levels of GM-CSF and SCF mRNAs were detected in untreated and c-myb sense-treated cultures (Fig. 3 , lanes a and b), whereas these were reduced by >90% in cultures exposed to c-myb antisense oligodeoxynucleotides (Fig. 3, lanes c) .
In contrast, IL-6 and IL-11 mRNA levels were not affected by the treatment with c-myb antisense oligodeoxynucleotides (not shown). IL-3 mRNA levels, barely detectable in stromal cells, were not modified in cultures treated with c-myb antisense oligodeoxynucleotides (not shown). Levels of B-actin mRNA, used as control, were constant.
Expression of GM-CSF and SCF in T98G Cells Constitutively Expressing c-myh To further investigate whether c-myb
expression is linked to that of GM-CSF and SCF, T98G glioblastoma cells, which express undetectable or low levels of endogenous c-myb, were transfected with a human c-myb cDNA driven by the SV40 promoter in the presence of the plasmid carrying the gene encoding hygromycin resistance. After selection, a mixed cell population of T98G cells transfected with a human c-myb cDNA driven by the early SV40 promoter (SV-m~,b T98G) (Fig. 4, lane b) and expressing the exogenous c-myl~ at high levels appeared to express higher levels of GM-CSF or SCF mRNA compared with T98G cells transfected only with the plasmid pLHL4 encoding hygromycin resistance (Fig. 4, lane a) . In SV-myb T98G cells the level of expression of GM-CSF and SCF mRNAs increased linearly with increase in the number of PCR cycles from 30 to 50 (not shown). Consistently, we were unable to detect SCF mRNA in control T98G cells, whereas GM-CSF mRNA could be detected only after as many as 50 cycles of PCR amplification (not shown). In SV-myb T98G cells, SCF mRNA levels appeared essentially identical to those found in HTB9 cells, whereas GM-CSF mRNA levels were less abundant than in PHA-stimulated PBMC. GM-CSF and SCF levels were measured in the cell-free culture supernatant from the control and the SV-myb-transfected T98G cells. A 3-4-and a 10-14-fold increase in secreted GM-CSF and SCF proteins, respectively, was detected in SV-myb T98G cells, compared with T98G cells transfected only with plasmid pLHL4 (Fig.  5) . Biological activity of the secreted cytokines was analyzed using the acute myelogenous leukemia MO7 cell line, whose proliferation is dependent on exogenously added IL-3, GM-CSF, or SCF (26) (27) (28) . Either 104 or 105 MO7 cells were seeded on a feeder layer of exponentially growing control or 
SV-myb-transfected
c-myb Transactivation of CAT Gene Expression Driven by the Human GM-CSF 5' Flanking Region Containing Putative Myb
Binding Sites. To assess the ability of c-myb to transactivate GM-CSF, transient expression assays were performed using a CAT reporter construct containing a 600-bp fragment of the human GM-CSF 5' flanking region found to contain several putative Myb binding sites. In Tk-ts13 hamster cells transfected at a 5:1 E / T ratio and assayed 48 h later, the SV40 c-myb effector plasmid induced a fivefold increase in CAT expression driven by the 600-bp GM-CSF 5' flanking segment ( Fig. 7 A) ; a similar level of transactivation of the GM-CSF 5' flanking sequence was found in SV-myb-Tk-ts13 cells constitutively expressing a human c-myb cDNA (Fig. 7 B, lane 2) . These latter cells were also transfected with the GM-CSFCAT2 construct in the presence of an excess (100:1, molar ratio) of a 22-base synthetic oligomer containing two canon-
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Szczylik et al. ical Myb binding sites or a 22-base synthetic oligomer with mutations at both sites. Transactivation of the GM-CSF CAT2 construct in the transfected cells was abolished by the wild type 22-mer competitor, but was unaffected by the mutated competitor ( Fig. 7 B, lanes 3 and 4) , suggesting that the transactivation of the GM-CSF promoter directly depended on c-myb expression and interaction with Myb binding sites.
To demonstrate that the 22-base oligomer containing two canonical Myb binding sites was nontoxic, CAT activity was analyzed in Tk-tk13 cells transfected with pSV-CAT in the presence (Fig. 7 C, lane 2) or in the absence (Fig. 7 C, lane I) of excess amount (100:1, molar ratio) of the synthetic oligomer. Levels of CAT activity were identical, confirming the specificity of the effects observed. Nevertheless, the findings reported here provide additional evidence that the role of c-myb is more general than previously thought and are consistent with similar findings in other nonhematopoietic systems, such as that of colon carcinoma and neuroblastoma cell proliferation and normal smooth muscle cell proliferation (11) (12) (13) .
To further investigate the relevance ofc-myb expression for stromal fibroblast cell function, we assessed whether cytokine production was regulated by c-rayb. Several lines of evidence support this hypothesis: (a) downregulation ofc-myb expression in stromal fibroblasts was associated with a specific decrease in GM-CSF and SCF mKNA levels; (b) constitutive expression of c-myb in a glioblastoma cell line with low or undetectable levels of endogenous c-myb was associated with upregulation of GM-CSF and SCF mRNAs and proteins; and (c) c-myb transactivated the expression of a reporter gene driven by a segment of the 5' flanking region of the human GM-CSF gene. Although we cannot exclude that downregulation of GM-CSF and SCF expression in marrow fibroblasts exposed to c-myb antisense oligodeoxynucleotides is, at least in part, a consequence of the growth inhibition of these cells, the observation that GM-CSF and SCF expression is upregulated in T98G cells whose growth is independent of c-myb expression, and that c-myb has a direct effect on the GM-CSF promoter, makes it unlikely that GM-CSF and SCF production are solely related to proliferative effects. The possible involvement of c-myb in regulating the expression of hematopoietic growth factors is not completely surprising in light of the recent observation of selective upregulation of insulin-like growth factor 1 (IGF-1) expression in murine fibroblasts constitutively expressing c-myb (32) . The significance of the functional link between c-myb and hematopoietic growth factors may not be restricted to marrow fibroblasts; a subset of primary leukemic cells expresses GM-CSF (33, 34) . Perhaps the overexpression of c-myb often observed in leukemic cells leads to autocrine cytokine expression that, in turn, contributes to the growth advantage of leukemic cells.
In summary, c-myb appears to play a role in regulating both proliferation and cytokine production in marrow fibroblasts. Although the mechanisms involved in this function remain unknown, our findings underscore the importance of the role ofc-myb in the regulation of cell physiology and suggest potential consequences of c-myb activation in hematological malignancies.
